| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | ADAPTIMMUNE THERAPEUTICS PLC | 296,934 | 3,581,000 | 0.13% | ||
| 102 | ALLIQUA BIOMEDICAL INC | 1,650,000 | 3,531,000 | 0.13% | ||
| 103 | HALOZYME THERAPEUTICS INC | 200,000 | 3,466,000 | 0.13% | ||
| 104 | BLUEBIRD BIO INCORPORATED | 49,345 | 3,169,000 | 0.11% | ||
| 105 | NOVAVAX INC COM | 358,000 | 3,004,000 | 0.11% | ||
| 106 | UNIQURE NV | 175,500 | 2,903,000 | 0.11% | ||
| 107 | FLEX PHARMA INC COM | 232,600 | 2,896,000 | 0.11% | ||
| 108 | INSMED INC COM PAR .01 | 156,600 | 2,842,000 | 0.10% | ||
| 109 | CYNAPSUS THERAPEUTICS INC | 180,407 | 2,785,000 | 0.10% | ||
| 110 | GRIFOLS S A SP ADR REP B | 83,000 | 2,689,000 | 0.10% | ||
| 111 | ALLSCRIPTS HEALTHCARE | 173,600 | 2,670,000 | 0.10% | ||
| 112 | LEXICON PHARMACEUTICALS | 197,641 | 2,631,000 | 0.10% | ||
| 113 | FORWARD PHARMA A/S | 136,547 | 2,594,000 | 0.09% | ||
| 114 | CARE CAP PPTYS INC | 84,316 | 2,578,000 | 0.09% | ||
| 115 | KITE PHARMA INCORPORATED | 41,000 | 2,526,000 | 0.09% | ||
| 116 | DBV TECHNOLOGIES | 65,600 | 2,382,000 | 0.09% | ||
| 117 | Esperion Therapeutics Inc | 102,800 | 2,288,000 | 0.08% | ||
| 118 | Momenta Pharmaceuticals Inc | 153,700 | 2,281,000 | 0.08% | ||
| 119 | MERRIMACK PHARMACEUTI | 1,485,000 | 2,199,000 | 0.08% | PRN | |
| 120 | AFFIMED N V | 294,213 | 2,095,000 | 0.08% | ||
| 121 | GW PHARMACEUTICALS PLC | 30,000 | 2,083,000 | 0.08% | ||
| 122 | TETRAPHASE PHARMACEUTICALS I COM | 192,322 | 1,929,000 | 0.07% | ||
| 123 | NEVRO CORP | 25,000 | 1,688,000 | 0.06% | ||
| 124 | CELLDEX THERAPEUTICS INC NEW | 105,800 | 1,659,000 | 0.06% | ||
| 125 | GALAPAGOS NV | 20,000 | 1,258,000 | 0.05% | ||
| 126 | BELLICUM PHARMACEUTICALS INC COM | 60,000 | 1,216,000 | 0.04% | ||
| 127 | CIDARA THERAPEUTICS INC | 52,500 | 901,000 | 0.03% | ||
| 128 | GENMARK DIAGNOSTICS INC COM | 93,349 | 724,000 | 0.03% | ||
| 129 | CHIMERIX INC | 47,800 | 428,000 | 0.02% | ||
| 130 | XENCOR INC COM | 20,000 | 292,000 | 0.01% | ||
| 131 | RMR GROUP INC | 7,441 | 107,000 | 0.00% | ||
| 132 | ZAFGEN INC COM | 13,307 | 84,000 | 0.00% | ||
| 133 | Gilead Sciences, Inc. | 278 | 27,000 | 0.00% | Call | |
| 134 | ABBVIE INC | 156 | 9,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-094941, filed 2016.02.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
